Echocardiographic characterization of a murine model of hypertrophic obstructive cardiomyopathy induced by cardiac-specific overexpression of epidermal growth factor receptor 2

Comparative Medicine

Volumn 66, Issue 4, 2016, Pages 268-277

  Sørensen, Lars L ^a,b   Bedja, Djahida ^a   Sysa Shah, Polina ^a   Liu, Hongyun ^a   Maxwell, Amanda ^a   Yi, Xu ^a   Pozios, Iraklis ^a   Olsen, Niels T ^c   Abraham, Theodore P ^a   Abraham, Roselle ^a   Gabrielson, Kathleen ^a  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b GENTOFTE UNIVERSITY HOSPITAL   (Denmark)

^c University of Copenhagen   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

EPIDERMAL GROWTH FACTOR RECEPTOR 2; ERBB2 PROTEIN, MOUSE; RECOMBINANT PROTEIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CARDIOVASCULAR PARAMETERS; CONTROLLED STUDY; DIASTOLIC DYSFUNCTION; ECHOCARDIOGRAPHY; HEART DISEASE; HEART EJECTION FRACTION; HEART LEFT VENTRICLE ENDDIASTOLIC VOLUME; HEART LEFT VENTRICLE ENDSYSTOLIC VOLUME; HEART LEFT VENTRICLE HYPERTROPHY; HEART LEFT VENTRICLE MASS; HEART PAPILLARY MUSCLE HYPERTROPHY; HYPERTROPHIC OBSTRUCTIVE CARDIOMYOPATHY; MALE; MIDCAVITY OBSTRUCTION; MOUSE; MUSCLE HYPERTROPHY; NONHUMAN; PROTEIN EXPRESSION; SYSTOLIC CIRCUMFERENTIAL STRAIN; SYSTOLIC LONGITUDINAL STRAIN; SYSTOLIC RADIAL STRAIN; SYSTOLIC RADIAL STRAIN RATE; ANIMAL; CARDIAC MUSCLE CELL; CARDIOMYOPATHY, HYPERTROPHIC; COLOR DOPPLER ECHOCARDIOGRAPHY; DIAGNOSTIC IMAGING; DIASTOLE; DISEASE MODEL; FEMALE; GENETICS; HEART PAPILLARY MUSCLE; HUMAN; METABOLISM; PATHOLOGY; PATHOPHYSIOLOGY; PULSED DOPPLER ECHOCARDIOGRAPHY; SYSTOLE; TRANSGENIC MOUSE;

ANIMALS; CARDIOMYOPATHY, HYPERTROPHIC; DIASTOLE; DISEASE MODELS, ANIMAL; ECHOCARDIOGRAPHY, DOPPLER, COLOR; ECHOCARDIOGRAPHY, DOPPLER, PULSED; FEMALE; HUMANS; MALE; MICE; MICE, TRANSGENIC; MYOCYTES, CARDIAC; PAPILLARY MUSCLES; RECEPTOR, ERBB-2; RECOMBINANT PROTEINS; SYSTOLE;

EID: 84983072006     PISSN: 15320820     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (34)

1. Abraham TP, Dimaano VL, Liang HY. 2007. Role of tissue Doppler and strain echocardiography in current clinical practice. Circulation 116:2597-2609.
2. Abraham TP, Jones M, Kazmierczak K, Liang HY, Pinheiro AC, Wagg CS, Lopaschuk GD, Szczesna-Cordary D. 2009. Diastolic dysfunction in familial hypertrophic cardiomyopathy transgenic model mice. Cardiovasc Res 82:84-92.
3. Afonso LC, Bernal J, Bax JJ, Abraham TP. 2008. Echocardiography in hypertrophic cardiomyopathy: the role of conventional and emerging technologies. JACC Cardiovasc Imaging 1:787-800.
4. Andrews TG, Lindsey ML, Lange RA, Aune GJ. 2013. Cardiac assessment in pediatric mice: strain analysis as a diagnostic measurement. Echocardiography 31:375-384.
5. Bland JM, Altman DG. 1986. Statistical methods for assessing agreement between 2 methods of clinical measurement. Lancet 327:307-310.
6. Carasso S, Yang H, Woo A, Vannan MA, Jamorski M, Wigle ED, Rakowski H. 2008. Systolic myocardial mechanics in hypertrophic cardiomyopathy: novel concepts and implications for clinical status. J Am Soc Echocardiogr 21:675-683.
7. de Gregorio C. 2007. Left ventricular dynamic obstruction by atypical papillary muscle morphology: is this finding so unusual in clinical practice? J Am Soc Echocardiogr 20:100-101.
8. Frey N, Luedde M, Katus HA. 2011. Mechanisms of disease: hypertrophic cardiomyopathy. Nat Rev Cardiol 9:91-100.
9. Gersh BJ, Maron BJ, Bonow RO, Dearani JA, Fifer MA, Link MS, Naidu SS, Nishimura RA, Ommen SR, Rakowski H, Seidman CE, Towbin JA, Udelson JE, Yancy CW. 2011. ACCF/AHA guideline for the diagnosis and treatment of hypertrophic cardiomyopathy: Executive summary: a report of the American College of Cardiology Foundation/American Heart Association Task Force on practice guidelines. Circulation.124:2761-2796.
10. Ho CY, Sweitzer NK, McDonough B, Maron BJ, Casey SA, Seidman JG, Seidman CE, Solomon SD. 2002. Assessment of diastolic function with Doppler tissue imaging to predict genotype in preclinical hypertrophic cardiomyopathy. Circulation 105:2992-2997.
11. Institute for Laboratory Animal Research. 2011. Guide for the care and use of laboratory animals, 8th ed. Washington (DC): National Academies Press.
12. Kazmierczak K, Muthu P, Huang W, Jones M, Wang Y, Szczesna-Cordary D. 2012. Myosin regulatory light chain mutation found in hypertrophic cardiomyopathy patients increases isometric force production in transgenic mice. Biochem J 442:95-103.
13. Klues HG, Roberts WC, Maron BJ. 1991. Anomalous insertion of papillary muscle directly into anterior mitral leaflet in hypertrophic cardiomyopathy. Significance in producing left ventricular outflow obstruction. Circulation 84:1188-1197.
14. Konstandin MH, Toko H, Gastelum GM, Quijada P, De La Torre A, Quintana M, Collins B, Din S, Avitabile D, Volkers M, Gude N, Fassler R, Sussman MA. 2013. Fibronectin is essential for reparative cardiac progenitor cell response after myocardial infarction. Circ Res 113:115-125.
15. Marian AJ, Roberts R. 2001. The molecular genetic basis for hypertrophic cardiomyopathy. J Mol Cell Cardiol 33:655-670.
16. Maron MS, Maron BJ, Harrigan C, Buros J, Gibson CM, Olivotto I, Biller L, Lesser JR, Udelson JE, Manning WJ, Appelbaum E. 2009. Hypertrophic cardiomyopathy phenotype revisited after 50 y with cardiovascular magnetic resonance. J Am Coll Cardiol 54:220-228.
17. Maron MS, Olivotto I, Zenovich AG, Link MS, Pandian NG, Kuvin JT, Nistri S, Cecchi F, Udelson JE, Maron BJ. 2006. Hypertrophic cardiomyopathy is predominantly a disease of left ventricular outflow tract obstruction. Circulation 114:2232-2239.
18. Matsubara K, Nakamura T, Kuribayashi T, Azuma A, Nakagawa M. 2003. Sustained cavity obliteration and apical aneurysm formation in apical hypertrophic cardiomyopathy. J Am Coll Cardiol 42:288-295.
19. McConnell BK, Fatkin D, Semsarian C, Jones KA, Georgakopoulos D, Maguire CT, Healey MJ, Mudd JO, Moskowitz IP, Conner DA, Giewat M, Wakimoto H, Berul CI, Schoen FJ, Kass DA, Seidman CE, Seidman JG. 2001. Comparison of 2 murine models of familial hypertrophic cardiomyopathy. Circ Res 88:383-389.
20. Menon SC, Eidem BW, Dearani JA, Ommen SR, Ackerman MJ, Miller D. 2009. Diastolic dysfunction and its histopathologic correlation in obstructive hypertrophic cardiomyopathy in children and adolescents. J Am Soc Echocardiogr 22:1327-1334.
21. Monserrat L, Gimeno-Blanes JR, Marin F, Hermida-Prieto M, Garcia-Honrubia A, Perez I, Fernandez X, de Nicolas R, de la Morena G, Paya E, Yague J, Egido J. 2007. Prevalence of fabry disease in a cohort of 508 unrelated patients with hypertrophic cardiomyopathy. J Am Coll Cardiol 50:2399-2403.
22. Nagueh SF, Appleton CP, Gillebert TC, Marino PN, Oh JK, Smiseth OA, Waggoner AD, Flachskampf FA, Pellikka PA, Evangelista A. 2009. Recommendations for the evaluation of left ventricular diastolic function by echocardiography. J Am Soc Echocardiogr 22:107-133.
23. Ohsato K, Shimizu M, Sugihara N, Konishi K, Takeda R. 1992. Histopathologic factors related to diastolic function in myocardial hypertrophy. Jpn Circ J 56:325-333.
24. Ram R, Mickelsen DM, Theodoropoulos C, Blaxall BC. 2011. New approaches in small animal echocardiography: imaging the sounds of silence. Am J Physiol Heart Circ Physiol 301:H1765-H1780.
25. Redfield MM, Jacobsen SJ, Burnett JC Jr, Mahoney DW, Bailey KR, Rodeheffer RJ. 2003. Burden of systolic and diastolic ventricular dysfunction in the community: appreciating the scope of the heart failure epidemic. JAMA 289:194-202.
26. Schaefer A, Klein G, Brand B, Lippolt P, Drexler H, Meyer GP. 2003. Evaluation of left ventricular diastolic function by pulsed Doppler tissue imaging in mice. J Am Soc Echocardiogr 16:1144-1149.
27. Serri K, Reant P, Lafitte M, Berhouet M, Le Bouffos V, Roudaut R, Lafitte S. 2006. Global and regional myocardial function quantification by 2-dimensional strain: application in hypertrophic cardiomyopathy. J Am Coll Cardiol 47:1175-1181.
28. St John Sutton MG, Lie JT, Anderson KR, O'Brien PC, Frye RL. 1980. Histopathologic specificity of hypertrophic obstructive cardiomyopathy. Myocardial fibre disarray and myocardial fibrosis. Br Heart J 44:433-443.
29. Sysa-Shah P, Sorensen LL, Abraham MR, Gabrielson KL. 2015. Electrocardiographic characterization of cardiac hypertrophy in mice that overexpress the ErbB2 receptor tyrosine kinase. Comp Med 65:295-307.
30. Sysa-Shah P, Xu Y, Guo X, Belmonte F, Kang B, Bedja D, Pin S, Tsuchiya N, Gabrielson K. 2012. Cardiac-specific over-expression of epidermal growth factor receptor 2 (ErbB2) induces pro-survival pathways and hypertrophic cardiomyopathy in mice. PLoS One 7:e42805.
31. Tanaka N, Dalton N, Mao L, Rockman HA, Peterson KL, Gottshall KR, Hunter JJ, Chien KR, Ross J Jr. 1996. Transthoracic echocardiography in models of cardiac disease in the mouse. Circulation 94:1109-1117.
32. Tardiff JC, Hewett TE, Palmer BM, Olsson C, Factor SM, Moore RL, Robbins J, Leinwand LA. 1999. Cardiac troponin T mutations result in allele-specific phenotypes in a mouse model for hypertrophic cardiomyopathy. J Clin Invest 104:469-481.
33. Varnava AM, Elliott PM, Sharma S, McKenna WJ, Davies MJ. 2000. Hypertrophic cardiomyopathy: the interrelation of disarray, fibrosis, and small vessel disease. Heart 84:476-482.
34. Yuan L, Wang T, Liu F, Cohen ED, Patel VV. 2010. An evaluation of transmitral and pulmonary venous Doppler indices for assessing murine left ventricular diastolic function. J Am Soc Echocardiogr 23:887-897.